October 16, 2026

Zilbrysq Autoinjector Approved for Generalized Myasthenia Gravis – MPR – Medical Professionals Reference

October 16, 2026

FDA Approves Autoinjector for Self-Administered Zilucoplan in Generalized Myasthenia Gravis – NeurologyLive

October 16, 2026

FDA Approves Zilucoplan Autoinjector for Myasthenia Gravis – Pharmacy Times

October 16, 2026

UCB: FDA green light for Zilbrysq auto-injector in myasthenia gravis – Idéal Investisseur

October 16, 2026

FDA approves autoinjector option for UCB’s myasthenia gravis drug By Investing.com – Investing.com Canada